Dyne Therapeutics, Inc.
NASDAQ: DYN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John G. Cox
- Employees
- 192
- Headquarters
- Waltham, United States
- IPO year
- 2020
- Market cap
- $3.4B
- Website
- https://www.dyne-tx.com
Loading DYN…
Loading profile data…Frequently asked questions about DYN
What does Dyne Therapeutics, Inc. (DYN) do?
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myo...
Where does DYN trade?
Dyne Therapeutics, Inc. (DYN) trades on the NASDAQ Global Select.
What sector is DYN in?
Dyne Therapeutics, Inc. (DYN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Dyne Therapeutics, Inc.?
John G. Cox is the chief executive officer of Dyne Therapeutics, Inc. (DYN).
Where is Dyne Therapeutics, Inc. headquartered?
Dyne Therapeutics, Inc. is headquartered in United States.
Does DYN pay a dividend?
Dyne Therapeutics, Inc. (DYN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DYN go public?
Dyne Therapeutics, Inc. (DYN) completed its initial public offering in 2020.